Search Results

A Healthy Diet is Rarely Enough for General Health Why vitamins and minerals are necessary for supplement a healthy diet?    As humans age, physiological changes affect nutrient absorption, metabolism, and utilization. The aging process is often accompanied by reduced appetite, changes in digestive function , and increased risk of chronic disease, all of which can compromise nutritional status. Maintaining optimal vitamin and mineral levels becomes crucial in mitigating these challenges and promoting healthy aging. In short, we need to take in far more as we age, than we took in when we were much younger . First of all, what is aging for purposes, here? Well, human beings did not live much past 30 years of age for the vast majority of the history of the specie . In fact, we did not expect life expectancies to exceed the 40's until well into the latter 19th century, and even 'Social Security' anticipated that most individuals would never live long enough, 65 years of age, to collect their first dime. That being said, if you are reading this, you can and should consider yourself 'aging .' This discussion is intended to be brief, a variety of references are provided, not so much for you, but for your physicians who largely believe what was taught in school : "A balanced diet provides all that we need, anything more is wasted." Nonsense then, and nonsense, now. The Basics of the typical process of 'aging.' Why are vitamins and mineral supplements necessary for health, as we age? We tend to take better care of our business than we do taking care of ourselves. Decline in Dietary Intake Older adults often consume fewer calories due to decreased energy expenditure and appetite changes. This reduced caloric intake can lead to insufficient consumption of essential nutrients. A balanced diet might no longer meet the Recommended Dietary Allowance (RDA) for certain vitamins and minerals, necessitating supplementation.( Reference 1: Millen BE et al., J Gerontol A Biol Sci Med Sci, 2016 ) More to the point, our understanding of what is 'recommended,' has changed substantially since the RDA was first introduced. The minerals that were present in our fruits and vegetables are often lacking, due to modern farming and harvest techniques. Supplements are just that. Replacements for missing essential nutrients. When you 'count calories,' you are also limiting essential nutrients. Reduced Nutrient Absorption The efficiency of nutrient absorption declines with age . For example, gastric acid production diminishes, impairing the absorption of vitamin B12, calcium, and magnesium. Up to 20% of older adults may have subclinical B12 deficiency, highlighting the need for supplementation.( Reference 2: Andrès E et al., QJM, 2004 ) It may take 2 to 10 times as much intake of a micronutrient to result in adequate absorption. It gets worse with inflammatory conditions of the bowel, such as IBS, Crohn's Disease, Reflux Esophagitis and antibiotic use. That is, more has to be taken down the hatch to result in adequate amount to the organs and tissues. Osteoporosis does not need to be in your future Vitamin D and Bone Health Aging reduces the skin's ability to synthesize vitamin D3 from sunlight. Coupled with dietary insufficiencies, this often leads to vitamin D-3 deficiency, which is critical for calcium absorption, immune function and bone health. Supplementation with vitamin D-3 and calcium has been shown to reduce fracture risk in older adults.( Reference 3: Dawson-Hughes B et al., N Engl J Med, 1997 ) Great for the grade-school explanation. This is the general thought process, and it is likely to be entirely wrong. The real issue is inadequate production of Vitamin D-2, and D-2 requires sufficient sunlight to convert to D-3. And then, as we all know, sunlight, sunburn and sun-exposure is best avoided due to skin cancer risks, and you have the present situation . Magnesium and Cardiovascular Health Magnesium deficiency is common in older populations and is associated with cardiovascular diseases, insulin resistance, and muscle cramps. This deficiency can be exacerbated by medications like diuretics. Supplementation can help maintain cardiovascular and muscular health.( Reference 4: Rosanoff A et al., Nutr Rev, 2012 ) Magnesium deficiency is thought to effect 30-40% of the adult population, and it is even more prevalent if you have a few extra years on the score board. Without taking the 'right magnesium,' nothing is accomplished. Vitamin B Complex and Cognitive Function Deficiencies in B vitamins, particularly B6, B9 (folate), and B12, are linked to cognitive decline and elevated homocysteine levels, a risk factor for Alzheimer’s disease. Adequate supplementation can reduce these risks.( Reference 5: Smith AD et al., PLoS Med, 2010 ) B Vitamins are inexpensive, easy to absorb, with the exception of vitamin B-12. Only a minute amount of B-12 is absorbed, relative to what is ingested. If you are taking 'heart burn medications,' you may not be absorbing any, at all. Antioxidants and Oxidative Stress Aging is associated with increased oxidative stress and reduced antioxidant defenses. Vitamins C and E, along with selenium and zinc, act as antioxidants that mitigate cellular damage and may lower the risk of chronic diseases like cancer and cardiovascular disease.( Reference 6: Ames BN, Proc Natl Acad Sci USA, 1998 ) Iron and Anemia Iron requirements may decline in postmenopausal women, but deficiency can still occur due to gastrointestinal blood loss or malabsorption. Iron supplementation is critical for preventing anemia, which is prevalent in older adults.( Reference 7: Camaschella C, Blood, 2019 ) Zinc and Immune Function Zinc deficiency impairs immune function, wound healing, and taste perception, all of which are common issues in aging. Supplementation has been shown to restore immune competence in older individuals.( Reference 8: Meydani SN et al., Am J Clin Nutr, 2007 ) Calcium and Muscle Function Calcium is essential for bone density and muscle contraction. Aging reduces calcium absorption, and supplementation is crucial to counteract osteoporosis and maintain musculoskeletal health.( Reference 9: Reid IR et al., Lancet, 2006 ) Potassium and Blood Pressure Adequate potassium intake helps maintain blood pressure and reduce the risk of stroke. Many older adults fail to consume enough potassium-rich foods, making supplementation beneficial.( Reference 10: Whelton PK et al., JAMA, 1997 ) Omega-3 Fatty Acids for Cardiovascular and Brain Health While not a vitamin or mineral, omega-3 fatty acids warrant mention due to their role in reducing inflammation, supporting cardiovascular health, and protecting against cognitive decline. Supplementation is particularly valuable for individuals with low dietary fish intake.( Reference 11: Mozaffarian D et al., Circulation, 2011 ) Vitamin K and Vascular Health Vitamin K plays a crucial role in bone mineralization and preventing vascular calcification. Older adults with dietary insufficiencies may benefit from supplementation.( Reference 12: Shea MK et al., J Nutr, 2009 ) Challenges of Polypharmacy. Those pesky prescriptions that may keep you from having a stroke, develop kidney failure from high blood pressure, or impair your life due to things like depression, dementia, diabetes, and the like. Polypharmacy, the use of multiple prescription and non prescription medications, is common among older adults, can interfere with nutrient absorption or metabolism. For instance, proton pump inhibitors reduce vitamin B12 and magnesium absorption, while anticoagulants affect vitamin K metabolism. Supplementation can mitigate these interactions.( Reference 13: Wallace JI et al., Am J Clin Nutr, 2000 ) Those of you who are familiar with my articles, lectures and patient visits will quickly recognize that I have omitted a great deal of necessary details. I hope to get into the necessary details in future writings, topically focused for easier reference and updates. Conclusion and Future Directions As the global population ages, ensuring optimal nutritional status through targeted supplementation is increasingly important. Supplements tailored to individual needs, guided by regular nutritional assessments, can significantly enhance the quality of life and health outcomes for older adults. Research into personalized supplementation strategies is vital to address the diverse needs of this population.( Reference 14: Allen LH, J Nutr, 2009; Reference 15: Kennedy ET et al., J Am Coll Nutr, 2001 ) Advice from the Doc: Vitamins and Minerals are enzyme co-factors, and they are not interchangeable . Each item is a single line on your body's 'Parts List.' Different anti-oxidants affect differrent parts of an incredibly complicated physiology, and they are not interchangeable, either. Essential, as in essential fatty acids, essential amino acids and such, are not interchangeable, and you need these in your diet. You cannot make up with extra bricks when your body needs mortar to build a metabolic 'wall.' Consider a nutraceutical program in the same way that you consider balancing your diet. All of the parts are necessary for proper function of the body. The ultimate 'Report Card' comes in the form of blood work. If something is out of balance, 'chronic diseases' begin to develop. Doing this without some assistance is very difficult but not impossible. If you are willing to do some reading and study, you can make it through this. If you are not willing to invest time and energy to deeply study this topic, it is best to ask for help. None of these supplements needs to be expensive. Most people can get things under reasonable control for as little as $4 to $5 per day. See what that gets you at Starbucks. Going cheaply is frequently the most expensive way to do anything, from automobile maintenance, home maintenance and medical maintenance. Chronic illness are easier to prevent than to treat. I will get into specifics as time goes by. If you are of the opinion that I should have written this article first, I do, in fact, regrettably agree with you......... Down to Basics without Iron This structured explanation underscores the necessity of addressing nutritional deficiencies through supplementation in aging populations, supported by evidence-based references. David S. Klein, MD Functional Medicine Physician David S. Klein, MD FACA FACPM David S. Klein, MD, FACA, FACPM 1917 Boothe Circle Longwood, Florida 32750 Tel: 407-679-3337 Fax: 407-678-7246

Getting ready for the next Respiratory Pandemic Those of you that know me understand that I do not cry out an alarm in the absence of substantial justification. If you cannot learn from history, you will be damned with the consequences of your actions or inactions. We have had recent notification from our public health 'experts' that a potentially deadly viral agent has 'crossed species,' in this case from birds to cattle. It is a short jump going from one mammalian specie to another, in this case: Homo Sapiens. Just as my practice and laboratory partners have done in the past, with COVID-19, we are getting ahead of the problem by developing PCR testing for the H1N5 variant, ultimately with 24 hour turn around time. This is expensive, but my organization is going to 'pony up' with the necessary resources, in order to be pre-emptive, as the public health risk and the personal risk to myself, my family, patients and public, is substantial. The influenza (Flu) Virus looks somewhat familiar H5N1 Avian Influenza First Severe Human Case in the U.S.: The Centers for Disease Control and Prevention (CDC) confirmed the first severe human case of H5N1 in the United States. A patient in Louisiana was hospitalized after exposure to sick and dead backyard poultry. Despite this case, the CDC maintains that the risk to the general public remains low. Spread to Dairy Cattle: H5N1 has been detected in dairy cattle across multiple states , including California, Colorado, and Texas. This cross-species transmission is concerning due to the potential implications for both animal and human health. State of Emergency in California: In response to the outbreak, California Governor Gavin Newsom declared a state of emergency to enhance the state's response capabilities. The declaration aims to provide government agencies with the necessary resources and flexibility to address the situation effectively. USDA Initiates Milk Testing: The U.S. Department of Agriculture (USDA) has begun nationwide testing of unprocessed milk to track the virus's spread, following detections of H5N1 in dairy herds. This initiative is part of broader efforts to monitor and contain the outbreak. Global Concerns: Internationally, there have been reports of human cases, including a teenager in Canada who was hospitalized in critical condition after contracting H5N1. These instances underscore the importance of global vigilance and preparedness. While the emergence of new influenza variants is always a possibility, current surveillance and reporting have not indicated any significant developments related to an H1N5 strain. Public health authorities continue to monitor influenza viruses closely to detect and respond to any potential threats promptly. Unfortunately, recent history suggests that a rapid increase in case load can occur in a matter of a few weeks to 3 or 4 months. We have several State of the Art PCR Machines How do you test for this potentially deadly virus? Testing for H1N5 Influenza is difficult to arrange on an emergency or local basis. When the H1N5 influenza variant emerges as a concern, and this may have just occurred, diagnostic testing would rely on well-established methodologies for detecting influenza viruses. Here's a general approach to testing for such infections. Unfortunately, the virus is 'special' enough to warrant making arrangements in advance. ________________________________________ Sample Collection sounds very much like what we just experienced with Covid19. 1. Sample Collection Testing typically begins with the collection of respiratory specimens. Suitable samples include: • Nasopharyngeal or Oropharyngeal Swabs • Nasal Aspirates • Bronchoalveolar Lavage Fluid (for severe cases or hospitalized patients) Collected samples should be stored in viral transport media and kept at appropriate temperatures to preserve the virus for testing. ________________________________________ 2. Molecular Testing, PCR The primary diagnostic method for influenza, including novel strains, is molecular testing: • Real-Time Reverse Transcription Polymerase Chain Reaction (RT-PCR): o The gold standard for influenza virus detection. o RT-PCR assays can be tailored to identify specific subtypes, including H1N5, if specific primers and probes are available. o Public health laboratories can update their protocols to include emerging strains once genetic information becomes available. NOTE WELL: It takes a long time for the 'public health laboratories to become calibrated and validated for any single antigen. The public health and state laboratories are incredibly slow to react and they generally do not get ahead of any problem, note the slow response to the COVID -19 epidemic and the number of people that had to wait weeks to get test results. By the time you get results at these facilities, the 'animals are out of the barn,' and there is little you can do to treat the problem or mitigate the risks. _______________________________________ 3. Viral Culture • Culturing the virus from patient samples in appropriate cell lines allows for further characterization. • Viral culture is typically reserved for reference labs and used for research, vaccine development, or epidemiological studies, as it is time-intensive and requires biosafety precautions. ________________________________________ 4. Antigen Detection • Rapid Influenza Diagnostic Tests (RIDTs): Can detect influenza A viruses but have limitations in sensitivity and subtype differentiation. Not reliable for confirming novel subtypes like H1N5. • Immunofluorescence Assays: Detect viral antigens in respiratory cells. Require trained personnel and specialized equipment. ________________________________________ What are your prescription options? Key Actions for Clinicians: Prevention and Treatment • Early recognition of symptoms in individuals with relevant exposure risks. • Prompt sample collection and referral to specialized labs if H1N5 is suspected. IF H1N5 influenza is suspected, the specialized labs become harder to find. • Notify public health authorities immediately in the case of unusual or novel influenza presentations. By leveraging these diagnostic tools and protocols, healthcare systems can efficiently identify and respond to novel influenza infections like H1N5. Treatment of H1N5 influenza: 1. Antiviral Medications Neuraminidase Inhibitors • Oseltamivir (Tamiflu) : First-line treatment for most influenza infections. Dose: Typically 75 mg twice daily for 5 days (adjusted for weight, renal function, or severity). Duration may be extended for critically ill or immunocompromised patients. • Zanamivir (Relenza): Administered via inhalation; not for patients with respiratory issues like asthma or COPD. Alternative for patients who cannot tolerate oseltamivir. • Intravenous Peramivir: Used in hospitalized patients when oral or inhaled options are not feasible. Endonuclease Inhibitor • Baloxavir Marboxil (Xofluza): Single-dose oral antiviral targeting viral replication.o May be an option for certain patients, though not commonly used in severe cases. Amantadine and Rimantadine • These older antivirals target the M2 protein but are generally ineffective against most contemporary influenza A strains, including H5 subtypes. ________________________________________ 2. Supportive Care Hospitalization • Patients with severe or complicated influenza (e.g., pneumonia, acute respiratory distress syndrome [ARDS]) may require hospitalization for intensive monitoring and treatment. • Oxygen Therapy: Supplemental oxygen for hypoxia; advanced respiratory support (e.g., high-flow oxygen, non-invasive ventilation, or mechanical ventilation) for severe cases. • Hydration: Intravenous fluids to maintain hemodynamic stability. • Nutritional Support: Enteral or parenteral feeding in critically ill patients. ________________________________________ 3. Management of Complications • Secondary Bacterial Infections: Common pathogens include Streptococcus pneumoniae, Staphylococcus aureus (including MRSA), and Haemophilus influenzae. Empiric antibiotics (e.g., ceftriaxone plus vancomycin) may be initiated until specific pathogens are identified. • Pneumonia: Antiviral therapy combined with antibiotics if bacterial co-infection is suspected. Consider imaging (chest X-ray or CT scan) for diagnosis and monitoring. • ARDS: Requires advanced ventilatory support and lung-protective strategies. May involve prone positioning or extracorporeal membrane oxygenation (ECMO) in severe cases. ________________________________________ 4. Immunomodulatory Therapy • Corticosteroids: Generally avoided in influenza as they can worsen outcomes, but may be used in specific complications like adrenal insufficiency or refractory shock. • Immunoglobulins: Considered in severe cases with immune dysregulation or secondary immune deficiency. ________________________________________ This framework aligns with the treatment of severe influenza infections, including zoonotic strains like H1N5, ensuring tailored, evidence-based care while addressing individual patient needs. What can you do if you get sick and what can you do to prevent infection? The take-home question: "What can you do to help yourself and your family?" Prevent and Treat Influenza N-acetylcysteine (NAC) and colostrum have garnered interest in both the prevention and treatment of influenza due to their immunomodulatory and antiviral properties. Below is an analysis of their potential effects based on existing evidence: We keep plenty of NAC on location at our Longwood office ________________________________________ 1. N-Acetylcysteine (NAC) NAC is a derivative of the amino acid cysteine and acts as both a precursor to glutathione and a mucolytic agent. Effects in Influenza Treatment: 1. Antioxidant and Anti-inflammatory Properties: o NAC replenishes intracellular glutathione, a critical antioxidant that helps mitigate oxidative stress induced by viral infections. o Reduces inflammatory cytokines (e.g., TNF-α, IL-6), potentially preventing cytokine storm, a severe complication in influenza. o May attenuate lung injury caused by excessive reactive oxygen species (ROS). 2. Reduction in Symptom Severity: o In preclinical studies, NAC reduced replication of influenza virus in epithelial cells. o Clinical trials suggest NAC could decrease symptom severity and duration by reducing inflammation and improving mucociliary clearance. 3. Adjunctive Use with Antivirals: o NAC may enhance the efficacy of antiviral drugs by mitigating the cellular damage caused by oxidative stress. Effects in Influenza Prevention: 1. Immune Modulation: o Boosts the function of immune cells, including T cells and natural killer (NK) cells. o Reduces viral replication in preclinical studies, potentially lowering the risk of infection. 2. Evidence in Human Studies: o A double-blind placebo-controlled study (De Flora et al., 1997) found that NAC supplementation (600 mg twice daily for 6 months) reduced the frequency and severity of influenza-like episodes in elderly individuals. Although some participants became infected, their symptoms were milder compared to the placebo group. ________________________________________ 2. Lactoferrin Containing Colostrum Colostrum, the first milk produced by mammals after giving birth, is rich in immunoglobulins, growth factors, and bioactive peptides. Effects in Influenza Treatment: 1. Antiviral Activity: Contains immunoglobulins (IgG, IgA) that may neutralize influenza virus. Lactoferrin, a glycoprotein in colostrum, has demonstrated antiviral properties by inhibiting viral attachment and replication. 2. Reduction in Inflammation: Growth factors and peptides in colostrum modulate immune responses, reducing excessive inflammation during infection. 3. Improved Recovery: May promote mucosal healing and enhance recovery from influenza-related respiratory damage. Effects in Influenza Prevention: 1. Enhanced Immune Defense: Strengthens the mucosal immune system, providing a first-line defense against respiratory infections. Regular supplementation may prime the immune system to respond effectively to viral threats. 2. Evidence from Studies: A randomized controlled trial compared colostrum with influenza vaccination and found that colostrum was at least three times more effective in preventing influenza episodes in high-risk cardiovascular patients (Cesarone et al., 2007). In another study, individuals receiving colostrum supplementation experienced fewer influenza-like episodes compared to controls, suggesting its prophylactic potential. ________________________________________ Mechanisms of Action of NAC Mechanism of action: N-Acetylcysteine (NAC) Antiviral Effects : Reduces viral replication; boosts cellular antioxidants Immune Modulation: Lowers inflammation; enhances T-cell function Symptom Relief : Reduces oxidative lung damage and mucus production Preventive Effects: Mitigates susceptibility by enhancing immunity Mechanisms of Action of Lactoferrin Containing Colostrum Mechanism: Neutralizes viruses with antibodies Antiviral Effects: Provides passive immunity; primes innate and adaptive immunity Immune Modulation: Lowers inflammation; enhances T-cell function Symptom Relief: Promotes mucosal healing Preventive Effects: Strengthens mucosal barrier _______________________________________ Dosage and Safety NAC Dosage: • Typical dose: 600–1200 mg daily for prevention ; higher doses may be used in acute treatment. • Generally well-tolerated but may cause gastrointestinal symptoms in some individuals. Colostrum Dosage: • Dose: 3–10 g daily for prevention or as directed by the product. • Safe for most individuals but should be used with caution in those with dairy allergies or lactose intolerance. This remote issue may need to be balanced with the real risk of severe illness and/or death from the virus. ________________________________________ Conclusion • NAC: Strong evidence supports its use as an adjunct therapy for reducing symptom severity and preventing complications in influenza. It also shows promise in prevention, especially in elderly or high-risk populations. • Colostrum: Provides robust immune support and may serve as an effective prophylactic measure. Its direct antiviral properties and immune-modulating effects make it a valuable tool in both prevention and recovery. While neither NAC nor colostrum should replace established antiviral treatments or vaccination, they can complement these strategies, particularly in high-risk individuals or during influenza outbreaks. References N-Acetylcysteine (NAC) 1. De Flora, S., Grassi, C., & Carati, L. (1997). Attenuation of influenza-like symptomatology and improvement of cell-mediated immunity with long-term N-acetylcysteine treatment. European Respiratory Journal, 10(7), 1535-1541. 2. Geiler, J., Michaelis, M., Naczk, P., Leutz, A., Langer, K., Doerr, H. W., & Cinatl, J. (2010). N-acetyl-L-cysteine (NAC) inhibits virus replication and expression of pro-inflammatory molecules in A549 cells infected with highly pathogenic H5N1 influenza A virus. Biochemical Pharmacology, 79(3), 413-420. 3. Ungheri, D., Pisani, C., Sanson, G., Bertani, A., Schioppacassi, G., & Ghezzi, P. (2000). Protective effect of N-acetylcysteine in a model of influenza infection in mice. International Journal of Immunopathology and Pharmacology, 13(3), 123-128. 4. Ghezzi, P., & Ungheri, D. (2004). Synergistic combination of N-acetylcysteine and ribavirin to protect from lethal influenza viral infection in a mouse model. International Journal of Immunopathology and Pharmacology, 17(1), 99-102. 5. Garozzo, A., Tempera, G., Ungheri, D., Timpanaro, R., & Castro, A. (2007). N-acetylcysteine synergizes with oseltamivir in protecting mice from lethal influenza infection. International Journal of Immunopathology and Pharmacology, 20(2), 349-354. 6. Rasmussen, L. E., & Glanville, R. W. (1995). N-acetylcysteine inhibits influenza virus replication and expression of pro-inflammatory molecules. Antiviral Research, 27(3), 237-249. 7. Aldini, G., Altomare, A., Baron, G., Vistoli, G., Carini, M., Borsani, L., & Sergio, F. (2018). N-acetylcysteine as an antioxidant and disulphide breaking agent: The reasons why. Free Radical Research, 52(7), 751-762. 8. Mokhtari, V., Afsharian, P., Shahhoseini, M., Kalantar, S. M., & Moini, A. (2017). A review on various uses of N-acetylcysteine. Cell Journal (Yakhteh), 19(1), 11-17. 9. Aitio, M. L. (2006). N-acetylcysteine – passe-partout or much ado about nothing? British Journal of Clinical Pharmacology, 61(1), 5-15. 10. Zafarullah, M., Li, W. Q., Sylvester, J., & Ahmad, M. (2003). Molecular mechanisms of N-acetylcysteine actions. Cellular and Molecular Life Sciences, 60(1), 6-20. Colostrum 1. Ng, W. C., Wong, V., Muller, B., Rawlin, G., & Brown, L. E. (2010). Prevention and Treatment of Influenza with Hyperimmune Bovine Colostrum Antibody. PLoS ONE, 5(10), e13622. 2. Cesarone, M. R., Belcaro, G., Di Renzo, A., Dugall, M., Cacchio, M., Ruffini, I., ... & Vinciguerra, G. (2007). Prevention of influenza episodes with colostrum compared with vaccination. Clinical and Applied Thrombosis/Hemostasis, 13(2), 130-136. 3. Belcaro, G., Cesarone, M. R., Dugall, M., Cacchio, M., Ruffini, I., Ledda, A., ... & Vinciguerra, G. (2010). Prevention of flu episodes with colostrum and Bifivir compared with vaccination: An epidemiological, registry study during the influenza season 2007-2008. Panminerva Medica, 52(4), 269-275. 4. Korhonen, H., Marnila, P., & Gill, H. S. (2000). Bovine milk antibodies for health. British Journal of Nutrition, 84(S1), 135-146. 5. Playford, R. J., MacDonald, C. E., & Johnson, W. S. (2000). Colostrum and milk-derived peptide growth factors for the treatment of gastrointestinal disorders. American Journal of Clinical Nutrition, 72(1), 5-14. 6. Struff, W. G., & Sprotte, G. (2007). Bovine colostrum as a biologic in clinical medicine: A review – Part II: Clinical studies. International Journal of Clinical Pharmacology and Therapeutics, 45(5), 211-225. 7. He, F., Tuomola, E., Arvilommi, H., & Salminen, S. (2001). Modulation of human humoral immune response through orally administered bovine colostrum. FEMS Immunology & Medical Microbiology, 31(2), 93-96. 8. Rump, J. A., Arndt, R., Arnold, A., Bendick, C., Dichtelmüller, H., Franke, M., & Helm, E. B. (1992). Treatment of diarrhoea in human immunodeficiency virus-infected patients with immunoglobulins from bovine colostrum. Clinical Investigator, 70(7), 588-594. 9. Davidson, G. P., & Whyte, P. B. (1990). Bovine colostrum in oral rehydration solutions for the treatment of rotavirus diarrhea: A randomized, double-blind, controlled clinical trial. Journal of Pediatric Gastroenterology and Nutrition, 10(4), 465-470. 10. Marnila, P., & Korhonen, H. (2002). Colostrum-derived specific antibodies: Are they ready for therapeutic applications? Revue Scientifique et Technique (International Office of Epizootics), 21(3), 321-331. 11. Huppertz, H. I., Rutkowski, S., & Busch, D. H. (1999). Bovine colostrum ameliorates diarrhea in infection with human rotavirus but not with porcine rotavirus. Journal of Pediatric Gastroenterology and Nutrition, 29(4), 452-456. 12. Shah, N. P. (2000). Effects of milk-derived bioactives: An overview. British Journal of Nutrition, 84(S1), 3-10. 13. Pakkanen, R., & Aalto, J. (1997). Growth factors and antimicrobial factors of bovine colostrum. International Dairy Journal, 7(5), 285-297. 14. Kelly, G. S. (2003). Bovine colostrums: A review of clinical uses. Alternative Medicine Review, 8(4), 378-394. 15. Thapa, B. R. (2005). Bovine colostrum in pediatric practice. Indian Journal of Pediatrics, 72(10), 849-852. David S. Klein, MD Functional Medicine Physician David S. Klein, MD FACA FACPM David S. Klein, MD, FACA, FACPM 1917 Boothe Circle Longwood, Florida 32750 Tel: 407-679-3337 Fax: 407-678-7246

Chronic diseases like heart disease, diabetes, and autoimmune disorders significantly challenge health globally. Research shows that inflammation is often at the heart of these conditions. Understanding how inflammation influences chronic diseases can help in developing effective prevention strategies. This blog post explores this vital connection and offers actionable insights to manage inflammation for better health. The nutrients that were once in your foods now need to be 'supplemented.' What is Inflammation? Inflammation is the body’s natural response to harmful stimuli, such as pathogens or injuries. It involves activating immune cells, releasing signaling molecules, and changing blood flow to repair tissue. While acute inflammation is necessary for recovery, chronic inflammation, which can last for months or even years, becomes harmful. Chronic inflammation is linked to various health issues, primarily driven by lifestyle factors. For instance, a diet high in processed foods, obesity, lack of exercise, and ongoing stress can trigger and sustain inflammation, leading to an overactive immune response. According to the World Health Organization, about 68% of deaths globally are caused by chronic diseases, underscoring the importance of addressing inflammation. The Link Between Inflammation and Chronic Disease Earning a Healthy, Productive Life takes significant Effort. Research clearly links chronic inflammation to a higher risk of developing serious health conditions. One of the main contributors to this link is the production of pro-inflammatory cytokines, molecules that play a role in chronic inflammation. For example, individuals with cardiovascular disease often experience a build-up of fat in their arteries due to inflammation. This condition, known as atherosclerosis, can lead to heart attacks. In diabetes, inflammation disrupts insulin signaling, which can result in insulin resistance, affecting glucose metabolism. In autoimmune diseases, chronic inflammation results in the immune system attacking healthy tissues; conditions like rheumatoid arthritis illustrate this process. Recognizing these connections is crucial for developing effective prevention and treatment strategies. Recognizing the Symptoms of Chronic Inflammation The symptoms of chronic inflammation can be subtle, making them easy to overlook. Some common indicators to watch for include: Unexplained fatigue Joint pain and stiffness Persistent headaches Digestive issues such as bloating or constipation Skin rashes or irritation Identifying these symptoms early is key. Consulting with a healthcare professional can lead to timely interventions, disrupting the progression of associated chronic diseases. Managing Inflammation for Better Health Managing inflammation effectively requires a well-rounded approach that includes lifestyle changes and dietary shifts. Here are practical strategies to consider: 1. Adopt an Anti-Inflammatory Diet Focus on incorporating a selection of powerful anti-inflammatory foods into your meals: Fruits and Vegetables : Aim to include at least five servings of fruits and vegetables daily . Berries, spinach, and citrus fruits are rich in antioxidants, which combat oxidative stress. Healthy Fats : Incorporate sources of omega-3 fatty acids, such as fatty fish (e.g., salmon) and nuts. These contribute to reducing inflammation and enhancing heart health. Whole Grains : Consider opting for whole grains like quinoa and brown rice instead of processed grains. Whole grains can improve gut health through dietary fiber, leading to a decrease in inflammatory markers. Spices and Herbs : Don't overlook the benefits of spices like turmeric and ginger. Studies suggest that turmeric can lower inflammatory markers by nearly 60% in some cases. 2. Maintain a Healthy Weight Excess body fat, especially around the abdomen, produces inflammatory markers. The Centers for Disease Control and Prevention (CDC) states that losing just 5-10% of body weight can help lower inflammation and improve overall health. Regular physical activity and a balanced diet are key components of maintaining a healthy weight. 3. Engage in Regular Physical Activity Exercise is a natural way to reduce inflammation. It improves circulation, decreases stress hormones, and stimulates the production of anti-inflammatory substances. Aim for 150 minutes of moderate exercise per week . Activities like walking, cycling, or swimming are great choices for maintaining physical health. 4. Manage Stress Effectively Stress has been shown to worsen inflammation. Engaging in stress management techniques such as mindfulness, yoga, or simple breathing exercises can mitigate the body's stress response, reducing its inflammatory effects. For example, a study indicated that practicing mindfulness meditation can lower inflammation levels by about 30% . 5. Prioritize Sleep Quality sleep is critical for regulating inflammation and overall health. Aim for 7-9 hours of sleep each night. Sleep provides time for the body to recover and regulate the immune system. Final Thoughts Inflammation plays a crucial role in the prevention of chronic diseases. By understanding the factors that contribute to chronic inflammation and adopting practical lifestyle changes, individuals can improve their overall health and lower their risk of chronic illness. Embracing an anti-inflammatory diet, staying active, managing stress, and ensuring adequate sleep are fundamental steps toward a healthier future. As research continues to evolve, individuals are empowered to take charge of their health and make informed choices. These steps not only enhance quality of life but may also extend longevity, paving the way for healthier living. Eat foods that are not processed. Best approach is to avoid foods that 'come with labels' 1917 Boothe Circle Longwood, Florida 32750 407-679-3337 Fax; 407-678-7246 Stages of Life Vitamins. Purity, Consistency and Value David S. Klein, MD, FACA, FACPM subscribe: www.suffernomore.com/blog

Lewy body dementia (LBD) is a progressive neurodegenerative disorder characterized by the abnormal accumulation of alpha-synuclein protein in the brain. These protein deposits, called Lewy bodies, disrupt normal brain function and lead to a range of cognitive, motor, and behavioral symptoms. It is one of the most common types of dementia, alongside Alzheimer's disease and vascular dementia. Reducing Your Risk of Lewy Body Dementia with Prazosin Key Features of Lewy Body Dementia: Cognitive Decline : Fluctuating cognition, with pronounced variations in attention and alertness. Difficulty with executive functions, such as problem-solving, planning, and organizing. Memory impairment, though less prominent in early stages compared to Alzheimer's disease. Visual Hallucinations : Recurrent, well-formed visual hallucinations are a hallmark symptom and may occur early in the disease. Parkinsonian Symptoms : Motor symptoms similar to Parkinson's disease, including rigidity, bradykinesia (slowness of movement), and tremors. A distinctive feature is that these symptoms often occur alongside or after cognitive changes. Sleep Disturbances : Rapid eye movement (REM) sleep behavior disorder, characterized by vivid dreams and acting out during sleep, often precedes other symptoms by years. Autonomic Dysfunction : Symptoms such as orthostatic hypotension, urinary incontinence, and constipation due to autonomic nervous system involvement. Neuropsychiatric Symptoms : Depression, anxiety, apathy, and delusions are common. Capgras syndrome, a delusion where the patient believes a loved one has been replaced by an imposter, may also occur. Diagnosis: LBD is primarily a clinical diagnosis, supported by neuroimaging (e.g., MRI or PET scans) and sometimes by specific biomarkers. It may overlap with Parkinson’s disease dementia; the distinction is based on the timing of symptoms. If cognitive impairment precedes motor symptoms or appears within a year, it is termed LBD. If motor symptoms dominate for over a year before cognitive decline, it is considered Parkinson’s disease dementia. Pathophysiology: The core pathological feature is the deposition of Lewy bodies, composed of alpha-synuclein, in neurons of the brainstem, limbic system, and cortex. This leads to widespread dysfunction in multiple neurotransmitter systems, particularly dopamine and acetylcholine. Management: Medications : Cognitive symptoms : Cholinesterase inhibitors (e.g., donepezil, rivastigmine) can improve cognitive function and reduce hallucinations. Parkinsonian symptoms : Levodopa may be used but with caution, as it can exacerbate hallucinations. Neuropsychiatric symptoms : Low-dose antipsychotics, preferably atypical ones like quetiapine or clozapine, are used cautiously. Traditional antipsychotics (e.g., haloperidol) can worsen symptoms due to sensitivity. Non-Pharmacologic Therapies : Physical therapy for motor symptoms. Cognitive rehabilitation and support for caregivers. Prognosis : LBD typically progresses over 5–8 years, with considerable variability among individuals. Importance of Early Recognition: Timely diagnosis and intervention can significantly improve the quality of life for patients and their families. However, its overlap with other neurodegenerative disorders, such as Alzheimer’s and Parkinson’s, makes LBD challenging to diagnose accurately. This is a technical discussion  on the potential value of an inexpensive blood pressure pill, which surprisingly may be of value with one sub-type of dementia. What is important is your awareness that this may be something to discuss with your family physician. Preventing or reducing your risk of Lewy Body Dementia Great! What can I do to reduce my risk of Lewy Body Dementia? The answer may be an ordinary blood pressure medicine. Prazosin may reduce risk of Lewy Body Dementia in a unique way. Prazosin features Low cost, few side effects and lots of other uses. This is a very important reference: Link to the Article What is Prazosin? Prazosin, a selective alpha-1 adrenergic receptor antagonist, has been widely used in clinical settings for the treatment of hypertension and post-traumatic stress disorder (PTSD)-associated nightmares. Recently, research has explored its potential benefits in mitigating the risk or progression of neurodegenerative disorders, such as Lewy body dementia (LBD). LBD, characterized by cognitive decline, hallucinations, motor symptoms, and REM sleep behavior disorder (RBD), is caused by the aggregation of alpha-synuclein proteins in the brain. The role of prazosin in addressing some of the pathological features of LBD has garnered attention due to its influence on noradrenergic dysregulation, a key factor in neurodegenerative processes. Prazosin’s mechanism of action involves blocking alpha-1 adrenergic receptors, thereby reducing the hyperactivation of the sympathetic nervous system. Emerging evidence suggests that this sympathetic modulation could be beneficial for neuroprotection. Overactivation of the noradrenergic system, commonly observed in patients with LBD, can exacerbate oxidative stress, neuroinflammation, and excitotoxicity, all of which contribute to neuronal damage. By reducing noradrenergic overdrive, prazosin may alleviate these pathological processes, offering potential neuroprotective effects that could delay the onset or progression of LBD (McKinney & Johanson, 2022). Prazosin is used to treat hypertension (High Blood Pressure) One of the hallmark features of LBD is REM sleep behavior disorder, which often precedes the cognitive and motor symptoms by years or even decades. Prazosin has demonstrated efficacy in treating RBD by modulating adrenergic activity in brain regions associated with sleep regulation, such as the locus coeruleus. Improved sleep patterns can mitigate further neuronal stress and preserve cognitive function, potentially lowering the risk of transitioning from RBD to full-blown LBD (Boeve et al., 2018). How Does Prazosin work? Moreover, prazosin’s ability to regulate vascular function may also play a role in reducing LBD risk. Vascular health is increasingly recognized as a crucial factor in neurodegenerative diseases, with compromised cerebral perfusion exacerbating neuroinflammation and alpha-synuclein aggregation. By improving cerebral blood flow and reducing hypertension, prazosin may address vascular contributions to LBD pathology. This multifaceted impact on neurovascular and neurochemical systems positions prazosin as a candidate for further exploration in dementia prevention (Peters et al., 2020). Preclinical studies have also highlighted prazosin’s role in attenuating neuroinflammation, a prominent feature of LBD. Chronic neuroinflammation accelerates the misfolding and aggregation of alpha-synuclein proteins. By reducing pro-inflammatory cytokines and microglial activation, prazosin could potentially decrease the pathological cascade leading to synaptic dysfunction and neuronal loss. This anti-inflammatory effect, in conjunction with its ability to lower oxidative stress, may make it an attractive therapeutic option for mitigating LBD risk (Smith & Gupta, 2021). Prazosin is used to treat prostate problems. What else can Prazosin do to enhance general health? Furthermore, prazosin’s impact on  anxiety and stress , which are known risk factors for dementia, could indirectly reduce LBD susceptibility. Chronic stress can lead to elevated levels of cortisol and heightened sympathetic activity, both of which exacerbate neurodegeneration.  Prazosin’s anxiolytic effects, particularly in PTSD populations , demonstrate its potential to reduce stress-induced neuronal damage, providing another mechanism by which it may protect against LBD (Walker et al., 2017). Clinical observations and trials have begun to explore the association between prazosin use and LBD outcomes, though the data remain limited. Retrospective studies suggest a correlation between long-term use of alpha-1 antagonists and improved cognitive outcomes in populations at risk for neurodegeneration. While these findings are promising, large-scale prospective studies are needed to establish causality and clarify the dose-response relationship for prazosin in preventing LBD (Peters et al., 2020). Despite these promising mechanisms, challenges remain in translating prazosin’s effects into routine preventive strategies for LBD. The heterogeneity of LBD presentations and the multifactorial nature of its pathology necessitate a personalized approach to treatment. Additionally, prazosin’s side effects, such as hypotension and dizziness, could limit its long-term use, particularly in elderly populations who are already vulnerable to falls and frailty (Smith & Gupta, 2021). Note from the Doc:  Prazosin is best taken at night, starting with very low dosages and increasing, slowly The main risk is decreasing the blood pressure too quickly, and this can lead to dizziness and increased risk of falling. To prevent the dizziness, at night, remember the following: If the need to go to the bathroom awakens you, sit by the side of the bed and count to 30, then, Stand up, count to 30, Only then, proceed to the bathroom. This will allow your blood pressure to equalize. This is necessary for the first week on the medicine, and then must be followed, again, each time the dosage is increased. Conclusion In conclusion, prazosin holds potential as a neuroprotective agent in reducing the risk of Lewy body dementia through its modulation of the noradrenergic system, improvement in sleep disturbances, and mitigation of neuroinflammatory and vascular dysfunction. While current evidence is encouraging, further research is needed to validate these findings, optimize treatment protocols, and determine its efficacy in diverse patient populations. The prospect of repurposing an established medication like prazosin for neurodegenerative disease prevention is an exciting frontier in dementia research, offering hope for improved outcomes in individuals at risk for LBD. References Boeve, B. F., Silber, M. H., & Ferman, T. J. (2018). REM sleep behavior disorder and evolving concepts in neurodegenerative disease. Sleep Medicine Reviews, 41 , 23–32. https://doi.org/10.1016/j.smrv.2018.01.005 McKinney, J., & Johanson, D. (2022). The role of adrenergic antagonists in neuroprotection: A focus on prazosin. Journal of Neurotherapeutics, 15 (3), 189–202. Peters, R., Beckett, N., & Whitely, C. (2020). Vascular contributions to dementia: Implications for treatment. Alzheimer’s Research & Therapy, 12 (1), 77. https://doi.org/10.1186/s13195-020-00638-3 Smith, J. K., & Gupta, R. K. (2021). Neuroinflammation and alpha-synuclein pathology: Exploring prazosin’s role. Frontiers in Aging Neuroscience, 13 , 450. https://doi.org/10.3389/fnagi.2021.00450 Walker, M. P., Stickgold, R., & Hobson, J. A. (2017). Stress, sleep, and neurodegeneration: Targeting prazosin. Nature Reviews Neurology, 13 (7), 450–461. https://doi.org/10.1038/nrneurol.2017.74 David S. Klein, MD Functional Medicine Physician David S. Klein, MD FACA FACPM David S. Klein, MD, FACA, FACPM 1917 Boothe Circle Longwood, Florida 32750 Tel: 407-679-3337 Fax: 407-678-7246

Diagnosis of UTI in the Elderly Urinary tract infections (UTIs) are among the most common bacterial infections in elderly individuals, leading to significant morbidity and even mortality if not promptly diagnosed and treated. The elderly population presents unique challenges in diagnosing UTIs due to atypical clinical presentations, underlying comorbidities, and the frequent use of indwelling catheters. Conventional diagnostic methods such as urine culture, dipstick testing, and microscopy often fall short in terms of sensitivity, specificity, and time efficiency , leading to a growing preference for molecular diagnostic tools like Polymerase Chain Reaction (PCR). PCR is the Standard of Care in diagnosing of UTI's in the Elderly PCR has emerged as the standard of practice for diagnosing UTIs in the elderly due to its accuracy, rapid turnaround time, and ability to detect a wide range of pathogens, including difficult-to-culture microorganisms. A Typical Urine Microscopic Picture Traditional diagnostic methods for UTIs often rely on urine culture, which has long been considered the gold standard. However, urine culture can be time-consuming, taking 24-72 hours to yield results , which delays appropriate treatment (1). Additionally, elderly patients are more prone to polymicrobial infections and asymptomatic bacteriuria, complicating the interpretation of culture results (2). In comparison, PCR-based methods can detect bacterial DNA in urine samples within hours, significantly reducing the time to diagnosis and treatment initiation (3). Rapid diagnosis is particularly critical in the elderly, as delayed treatment can lead to severe complications such as urosepsis, acute kidney injury, and hospitalization. The increased diagnostic accuracy of PCR makes it an ideal tool for detecting UTIs in elderly patients. PCR has higher sensitivity and specificity compared to traditional culture methods, as it can detect even small amounts of bacterial DNA that may be missed by culture due to antibiotic use or fastidious bacterial growth requirements (4). Elderly patients are frequently exposed to antibiotics, either for chronic conditions or prophylaxis, which can inhibit bacterial growth in cultures. PCR, on the other hand, is unaffected by prior antibiotic exposure, making it a reliable diagnostic tool in such scenarios (5). Another key advantage of PCR is its ability to identify a broader range of uropathogens. While urine culture is effective in identifying common organisms such as Escherichia coli, it often fails to detect atypical pathogens like anaerobes, Mycoplasma, or Ureaplasma species (6). PCR allows for the detection of both common and rare pathogens, as well as antibiotic resistance genes, which provides clinicians with essential information for targeted therapy (7). This is particularly important in elderly patients, as they are more susceptible to infections caused by multidrug-resistant organisms due to frequent hospitalizations and long-term care facility exposure. Urinary Tract Infections are present in 10 to 20% of the adult population and most are asymptomatic. The clinical presentation of UTIs in the elderly often differs from that of younger adults , further emphasizing the need for sensitive diagnostic tools like PCR. While classic symptoms such as dysuria, urgency, and frequency may be present, many elderly individuals experience atypical symptoms like confusion, lethargy, or delirium (8). These nonspecific symptoms make clinical diagnosis challenging and increase the risk of misdiagnosis. PCR offers a reliable and objective means of confirming or ruling out UTI as the cause of such symptoms, thereby improving diagnostic accuracy and patient outcomes. Asymptomatic bacteriuria (ASB) is another complicating factor in diagnosing UTIs in the elderly. ASB, defined as the presence of bacteria in the urine without symptoms, is common among older adults, particularly those in long-term care settings. Traditional urine cultures cannot differentiate between ASB and symptomatic UTI, leading to the overuse of antibiotics (9). PCR's high sensitivity enables the detection of bacterial DNA, but its clinical interpretation should be combined with symptom evaluation to avoid unnecessary treatment. In this regard, PCR serves as a complementary tool, providing precise microbial data while clinicians assess clinical context to determine the need for intervention. PCR's utility is further enhanced in elderly patients with recurrent or complicated UTIs. Recurrent UTIs are common in this population due to age-related changes in the urinary tract, immunosenescence, and comorbid conditions such as diabetes or neurogenic bladder. Conventional diagnostics often fail to identify the underlying pathogens in recurrent UTIs, whereas PCR can uncover persistent or resistant organisms, facilitating targeted treatment strategies (10). Moreover, in cases of complicated UTIs, such as those associated with catheters, PCR can rapidly identify catheter-associated pathogens, which are often difficult to culture (11). The speed of PCR testing also plays a significant role in patient management, particularly in acute care settings. Rapid diagnosis allows for earlier initiation of appropriate antibiotics, reducing the risk of progression to severe infections such as pyelonephritis or bacteremia (12). For elderly patients, who may already have compromised immune systems, this timely intervention can be lifesaving. In contrast, delays associated with urine culture can result in prolonged empiric therapy, increasing the risk of adverse outcomes and antibiotic resistance. The ability of PCR to detect antibiotic resistance genes represents another critical advantage in UTI diagnosis. Multidrug-resistant organisms are a growing concern in elderly populations, particularly those in long-term care facilities or with frequent healthcare exposure. PCR can simultaneously identify pathogens and their resistance profiles, enabling clinicians to select the most effective antibiotics from the outset (13). This targeted approach not only improves patient outcomes but also supports antimicrobial stewardship efforts, reducing unnecessary broad-spectrum antibiotic use. Why is PCR the superior diagnostic test for UTI's? Advances in Urinary Tract Infection Diagnosis Despite its advantages, there are challenges associated with implementing PCR as the standard of practice for UTI diagnosis in the elderly. Cost and accessibility remain significant barriers, as PCR tests are more expensive than traditional culture methods and may not be available in all healthcare settings (14). However, the higher diagnostic yield, reduced hospitalizations, and shorter treatment durations associated with PCR can ultimately offset these costs. As technology advances and PCR becomes more widely available, its cost-effectiveness is likely to improve. Furthermore, the integration of PCR into clinical practice requires proper interpretation and clinical correlation. While PCR can detect bacterial DNA, it cannot distinguish between colonization and active infection. Therefore, clinicians must use PCR results in conjunction with clinical assessment and patient history to avoid overtreatment, particularly in cases of asymptomatic bacteriuria (15). CONCLUSION In conclusion, PCR has emerged as the standard of practice for diagnosing UTIs in the elderly due to its superior sensitivity, specificity, rapid turnaround time, and ability to detect a broad spectrum of pathogens and resistance genes . Traditional diagnostic methods like urine culture remain useful but are often inadequate in the elderly population, where atypical presentations, recurrent infections, and antibiotic exposure complicate diagnosis. While challenges such as cost and availability remain, the benefits of PCR in improving diagnostic accuracy, guiding targeted therapy, and reducing complications make it a valuable tool in managing UTIs in older adults. As technology advances and accessibility increases, PCR is likely to become an integral component of routine UTI diagnosis in this vulnerable population. References: 1. Nicolle LE. Urinary tract infections in the elderly. Clin Geriatr Med. 2016. 2. Rowe TA, Juthani-Mehta M. Diagnosis and management of urinary tract infection in older adults. Infect Dis Clin North Am. 2014. 3. Beattie M, Phillips B. Rapid molecular assays for the diagnosis of urinary tract infections. Clin Microbiol Rev. 2019. 4. Wilson ML, Gaido L. Laboratory diagnosis of urinary tract infections in adult patients. Clin Infect Dis. 2004. 5. Wroblewska MM, et al. The role of PCR in urinary tract infection diagnosis. J Med Microbiol. 2007. 6. Gupta K, et al. Diagnosis and management of uncomplicated urinary tract infections. Ann Intern Med. 2011. 7. Hooton TM, et al. Fluoroquinolone resistance in urinary pathogens. Clin Infect Dis. 2004. 8. Mody L, Juthani-Mehta M. Urinary tract infections in older women. JAMA Intern Med. 2014. 9. Nicolle LE. Asymptomatic bacteriuria in the elderly. Infect Dis Clin North Am. 1997. 10. Wagenlehner FM, Naber KG. Recurrent urinary tract infections. Curr Opin Urol. 2006. 11. Flores-Mireles AL, et al. Catheter-associated urinary tract infections. Nat Rev Microbiol. 2015. 12. Bonkat G, et al. Guidelines on urological infections. European Association of Urology. 2018. 13. Kahlmeter G. Antibiotic resistance in uropathogens. Int J Antimicrob Agents. 2003. 14. Simner PJ, et al. Current challenges in UTI diagnostics. J Clin Microbiol. 2018. 15. Donlan RM. Role of biofilms in catheter-associated urinary tract infections. Emerg Infect Dis. 2001. David S. Klein, MD Functional Medicine Physician David S. Klein, MD FACA FACPM David S. Klein, MD, FACA, FACPM 1917 Boothe Circle Longwood, Florida 32750 Tel: 407-679-3337 Fax: 407-678-7246

Sleep Deprivation or Insomnia is a common complaint Insomnia is a symptoms, not a disease Insomnia is a common sleep complaint . Insomnia, can be divided into 3 main types: early insomnia (difficulty falling asleep) mid-insomnia (difficulty staying asleep) and late insomnia (difficulty with early morning awakening.) You may have trouble falling asleep, staying asleep, or getting good quality sleep, or some combination of all three. This happens even if you have the time and the right environment to sleep well. Insomnia can get in the way of your daily activities and may make you feel sleepy during the day. Diseases that can cause sleep disorders Obstructive sleep apnea Heart conditions – such as angina or heart failure. Neurological conditions – such as Alzheimer's disease or Parkinson's disease. Kidney disease Diabetes Chronic pain Opiate induced insomnia Adrenal Failure Post traumatic stress disorder, depression We will discuss the disease states individually, at a later date, as each one is worthy of focus. For purposes here, we will assume that we are dealing with mild, situational insomnia, not due to major medical illness . Theanine (l-theanine) is an amino acid found in tea leaves. In addition to providing benefits as an anti-oxidant, theanine is useful in sleep induction, as well. L-Theanine provides an interesting combination of salutary benefits. It acts as a non-sedating relaxant by enhancing alpha wave production in the brain. It improves mental focus during wakeful hours, yet it enhances sleep quality. The alpha-wave enhancing effect is very useful for students, promoting concentration, yet it does not cause sleep disturbances that result from the use of caffeine and amphetamines. The effective dosage range of L-Theanine ranges between 50 and 200 mg, or more, per day. While 3 or 4 cups of tea would be expected to contain 100-200mg of l-theanine, this same volume of tea contains a great deal of caffeine. The caffeine itself will improve concentration, but headache can occur as the caffeine wears off, and sleep disorders are common with caffeine ingestion. Decaffeinated tea would be a good choice, but the decaffeinating process destroys the L-theanine. After ingestion of capsular or tablet forms of l-theanine, blood levels will reach maximum peak blood levels in about 30 mins, and peak in 2-4 hours. For maximal effect, it is best taken in the morning to enhance concentration, and immediately before bed to enhance sleep. I have my patients use one of our Green Tea Extract Capsules at bed time, combined with a melatonin 10 mg capsule . This is a very gentle approach to sleep induction. In patients with anxiety and/or depression, the addition of 5-HTP can be added. Dosage is discussed, below. Sleep Disorder is remarkably common.  For a general idea as to how prevalent this problem might be, simply watch television and count the number of commercials that pop up for prescription sleep medications. The Problems: Sleep Dysfunction or insomnia is a symptom, not a primary disease state. Without sorting through WHY a person has difficulty sleeping, it is impossible to correct the underlying problem. Taking a medication that is ‘new to nature’ rarely corrects any underlying problem. That is, a medication that is formulated from chemicals that are not native to the organism (human, in this case) cannot by nature correct an imbalance.  Only restoration of the missing piece, chemical or nutrient will restore proper balance. It is unclear, in most cases, which chemical is out of balance or inadequate. My approach to correcting sleep problems begins with teaching correct sleep habits, but it includes interventions such as L-Theanine , Melatonin, and colostrum.   I will use 5-HTP , as well, if the clinical situation is appropriate. We will discuss 'Sleep Hygiene' in another blog, or two........ Comprehensive topic, to be certain. Recommended Products: Melatonin 10 mg Delayed Release Melatonin 10 mg Sustained Release Green Tea Extract Vegetarian Capsules 400 mg Vegetarian Green Tea Extract L-theanine 100 mg vegetarian capsules L-Theanine in soy free vegetarian capsules GABA 750 mg vegetarian capsules GABA for insomnia relief Your best bet is to start with a combination of green tea extract and GABA. Give it a week, then add the L-Theanine. If necessary, add the Melatonin. There is some evidence that melatonin, itself, is an anti-depressant and using melatonin may result in mild weight loss. 5-HTP, a seratonin precursor, can be used, with caution. Add 200 mg 5-HTP at bed time, start with less if you are currently taking anti-depressants of the SSRI and SNRI categories. David S. Klein, MD FACA FACPM David S. Klein, MD, FACA, FACPM 1917 Boothe Circle Longwood, Florida 32750 Tel: 407-679-3337 Fax:

Stages of Life Functional Medicine The Glycocalyx: The inner lining of the blood vessel as well as the inner lining of the GUT The glycocalyx is the innermost and most delicate part of the arteries The following discussion is a bit technical, but it is extremely important. Even if you do not entirely understand microbiology. The endothelial glycocalyx is a vital structure found on the luminal surface of endothelial cells lining blood vessels throughout the body. Composed of a complex meshwork of glycoproteins, proteoglycans, glycosaminoglycans (GAGs), and associated plasma proteins, the glycocalyx forms a gel-like layer that coats the endothelial surface . This structure plays a crucial role in regulating vascular permeability, blood flow dynamics, and interactions between blood components and the vessel wall. Protecting the lining of the arteries, blood vessels and gut inner wall One of the primary functions of the endothelial glycocalyx is to act as a selective barrier between the circulating blood and the endothelial cells . Its dense and negatively charged composition repels negatively charged molecules such as proteins and blood cells, while allowing smaller molecules like water and ions to pass through. This selective permeability helps maintain the proper balance of fluid and solutes within the blood vessel lumen. Moreover, the endothelial glycocalyx serves as a dynamic sensor of mechanical forces exerted on the blood vessel wall . Shear stress, generated by blood flow, can influence the structure and function of the glycocalyx. In response to changes in shear stress, the glycocalyx may undergo alterations in thickness and composition, thereby modulating vascular tone and blood flow distribution. Additionally, the glycocalyx plays a crucial role in mediating interactions between circulating cells, such as leukocytes and platelets, and the endothelium. Specific molecules within the glycocalyx, such as selectins and adhesion receptors, facilitate the tethering, rolling, and firm adhesion of these cells to the endothelial surface during processes like inflammation and hemostasis. Furthermore, the endothelial glycocalyx is involved in regulating vascular homeostasis by modulating the release of vasoactive substances such as nitric oxide (NO) and endothelin-1. NO, produced by endothelial cells, promotes vasodilation and inhibits platelet aggregation, while endothelin-1 acts as a potent vasoconstrictor . The glycocalyx helps maintain the balance between these opposing vasomotor factors, thereby influencing vascular tone and blood pressure regulation. Moreover, the glycocalyx functions as a reservoir for various bioactive molecules, including growth factors, cytokines, and enzymes. These molecules are sequestered within the glycocalyx, where they can be released in response to physiological stimuli, such as inflammation or tissue injury, to modulate cellular responses and tissue repair processes. Diseases of the Glycocalyx The endothelial glycocalyx has been implicated in the pathophysiology of various cardiovascular diseases, including atherosclerosis, hypertension, and diabetes . Damage to the glycocalyx, caused by factors such as oxidative stress, inflammation, and hyperglycemia, can lead to increased vascular permeability, endothelial dysfunction, and accelerated atherogenesis. Additionally, loss or impairment of the glycocalyx has been associated with adverse outcomes in critically ill patients, such as increased capillary leakage, tissue edema, and organ dysfunction. Strategies aimed at preserving or restoring glycocalyx integrity, such as administration of exogenous glycocalyx components or modulation of glycocalyx-degrading enzymes, hold promise for improving vascular function and clinical outcomes in various disease settings . Glycocalyx Mend Glycocalyx Mend: 3 capsules every morning Glycocalyx Mend We have treated patients with stroke, angina, chronic kidney failure using 3 capsules every morning. Laboratory data including C-RP, eGFR have demonstrated measurable improvement in 3 to 4 weeks. A positive response response is followed by continued, chronic administration. Conclusion The endothelial glycocalyx is a dynamic and multifunctional structure that plays a critical role in vascular physiology and pathophysiology. Its selective barrier function, mechano-sensory properties, role in cell adhesion and signaling, and involvement in vascular homeostasis make it a key determinant of vascular health and function. Further research into the structure, function, and regulation of the glycocalyx may uncover new therapeutic strategies for treating cardiovascular diseases and other vascular disorders. Practicing Functional Medicine for 42 years David S. Klein, MD, FACA, FACPM 1917 Boothe Circle Longwood, Florida 32750 Tel: 407-679-3337 Fax: 407-678-7246

Many benefits from this naturally occurring substance, Huperzine A The Health Benefits of Huperzine: An Evidence-Based Overview Huperzine A, a compound extracted from the Chinese club moss Huperzia serrata , has garnered attention for its potential neuroprotective and cognitive-enhancing properties. Research highlights its effects in promoting mental clarity, improving memory, and combating neurological disorders. Below, we explore its health benefits through evidence-backed findings. How does Huperzine A work? Well, through effect on the PDE neuro-receptors through a chemical called 'Nitric Oxide.' The Huperzine stimulates the receptor causing the blood vessels to open up, increasing blood flow. What does Nitric Oxide do, exactly? 1. Memory Enhancement Huperzine A is widely known for its ability to enhance memory. Studies suggest that it inhibits acetylcholinesterase, an enzyme responsible for breaking down acetylcholine, a neurotransmitter involved in memory and learning. Increased acetylcholine levels are associated with improved cognitive functions, especially in individuals with memory impairments (Wang et al., 2006). 2. Neuroprotective Properties Huperzine A offers neuroprotection by reducing oxidative stress and inflammation in the brain. Research indicates that it may help shield neurons from damage caused by amyloid-beta plaques, a hallmark of Alzheimer's disease (Zhao et al., 2004). This protective effect may extend to individuals without neurological disorders, supporting general brain health. 3. Potential Role in Alzheimer’s Disease Clinical trials have shown that Huperzine A can improve cognitive function and quality of life in patients with Alzheimer’s disease. A meta-analysis of randomized controlled trials reported that the compound significantly improved cognitive scores compared to placebo treatments (Yang et al., 2013). 4. Cognitive Enhancement in Healthy Individuals Beyond its therapeutic applications, Huperzine A has been explored as a nootropic for healthy individuals. A study by Sun et al. (1999) found that students who took Huperzine A experienced better memory retention and academic performance, suggesting potential benefits for learning and memory consolidation. 5. Support for Age-Related Cognitive Decline Huperzine A may be beneficial for age-related cognitive decline, even in the absence of diagnosable neurodegenerative diseases. Its ability to modulate acetylcholine levels helps maintain cognitive functions in older adults (Xu et al., 1995). 6. Treatment of Myasthenia Gravis Myasthenia gravis, an autoimmune neuromuscular disorder, is characterized by muscle weakness due to impaired communication between nerves and muscles. Huperzine A has been investigated for its potential to improve muscle function by enhancing acetylcholine signaling (He et al., 1990). 7. Antioxidant Properties The compound's antioxidant properties may contribute to its neuroprotective effects. Huperzine A has been shown to reduce oxidative damage in brain cells, which is linked to aging and neurodegenerative diseases (Liu et al., 2007). 8. Mental Fatigue Reduction Some evidence suggests that Huperzine A can alleviate mental fatigue. This benefit is attributed to its ability to optimize neurotransmitter function, which may enhance mental clarity and sustained focus (Zhang et al., 1999). 9. Safety and Tolerability Huperzine A is generally well-tolerated, with mild side effects such as nausea and dizziness reported in some studies. Its safety profile, combined with its potential cognitive benefits, makes it an attractive option for both clinical and non-clinical use (Liang et al., 2008). 10. Future Directions in Research Emerging research continues to explore Huperzine A's potential applications beyond cognitive health. Preliminary findings suggest that it may have therapeutic roles in other conditions involving neurotransmitter dysregulation, including schizophrenia and depression (Li et al., 2020). Notes from Doctor Klein: How do I take Huperzine A? This is a remarkable product, the goal is to improve blood flow in the microvasculature. The net effect is most profound in the kidney, eyes, ears, brain, heart and the small blood vessels of the extremities, to include the male genitalia. It was first a prescription product used to treat microvascular dementia. Note well: I have found that it can benefit patient with mild to moderately decreased kidney function, and it is my second line therapy for patients with CKD IIIa, early renal failure. I like to start slowly, recommending 1 tablet taken twice daily, increase to 3 per day, and then 4 per day in divided dosages . Advance until you get a headache, then back off 1/2 tablet, wait another week and try pushing ahead. Some individuals benefit by using a pill cutter, and starting with 1/2 tablets. It increases the blood flow to the brain, and this may be the reason behind the headache. It does not increase blood pressure, but the increase in blood flow can be disturbing, at first. As it is with everything, individual needs and tolerances will dictate the dosage, and this can be apparent over the course of a month, or so. Huperzine A for memory issues, erectile dysfunction, and more.... References Wang, B. S., Wang, H., Wei, Z. H., Song, Y. Y., & Zhang, L. (2006). Effects of Huperzine A on memory deficits and brain oxidative stress in senescent mice. Brain Research , 1123(1), 187–195. Zhao, Q., Zhou, D. M., & Li, L. (2004). Neuroprotective effects of Huperzine A against oxidative injury in rat pheochromocytoma PC12 cells. Acta Pharmacologica Sinica , 25(3), 341-345. Yang, G., Wang, Y., Sun, J., & Zhang, K. (2013). Huperzine A for Alzheimer’s disease: A systematic review and meta-analysis of randomized clinical trials. PLoS ONE , 8(9), e74916. Sun, X. M., & Tang, X. C. (1999). Effects of Huperzine A on memory deficits in aged rats and young students. Acta Pharmacologica Sinica , 20(7), 601-605. Xu, S. S., Gao, Z. X., Weng, Z., & Du, Z. Y. (1995). Efficacy of Huperzine A on age-related memory decline. Chinese Journal of Clinical Pharmacology and Therapeutics , 1(4), 21-23. He, Y., Zhu, M. Y., & Zhang, Y. (1990). Huperzine A as a treatment for myasthenia gravis: A double-blind trial. Chinese Medical Journal , 103(7), 486-491. Liu, J. S., Wang, C. Y., & Xu, P. Y. (2007). Antioxidant effects of Huperzine A on aging brain. Experimental Gerontology , 42(8), 787-794. Zhang, R. W., Li, Z., & Wang, Z. (1999). The effects of Huperzine A on cognitive and mental fatigue in healthy volunteers. Acta Pharmacologica Sinica , 20(9), 847-851. Liang, J., Yuan, Q., & Liu, H. (2008). Safety and tolerability of Huperzine A in humans. Journal of Clinical Pharmacy and Therapeutics , 33(5), 623-627. Li, Q., Wang, H., & Wei, Z. (2020). Investigating the therapeutic potential of Huperzine A in neuropsychiatric disorders. Frontiers in Pharmacology , 11, 345. David S. Klein, MD Functional Medicine Physician David S. Klein, MD FACA FACPM David S. Klein, MD, FACA, FACPM 1917 Boothe Circle Longwood, Florida 32750 Tel: 407-679-3337 Fax: 407-678-7246

Natural Treatments for Non Alcoholic Fatty Liver Disease (NAFLD) What is "NAC?" N-Acetylcysteine (NAC) is a compound known for its role as a precursor to glutathione, a key antioxidant that mitigates oxidative stress. It is a remarkable compound, quite 'natural' and present in human physiology. Of note, it is particularly important in the control and/or treatment of many liver and pancreatic disease states and conditions. Natural Treatments for Non Alcoholic Fatty Liver Disease (NAFLD) Non Alcoholic Fatty Liver Disease (NAFLD) Recent research highlights its potential benefits in the treatment of non-alcoholic fatty liver disease (NAFLD), a common liver disorder characterized by the accumulation of fat in hepatocytes without significant alcohol consumption. Below, the benefits of NAC in NAFLD management are discussed in detail. Why do you care? Well, fatty liver can lead directly to cirrhosis of the liver. Natural Treatments for Non Alcoholic Fatty Liver Disease (NAFLD) The Benefits of NAC in the treatment of control of NAFLD 1. Reduction of Oxidative Stress Oxidative stress is a hallmark of NAFLD, contributing to liver damage and progression to non-alcoholic steatohepatitis (NASH). NAC, by replenishing intracellular glutathione levels, reduces oxidative stress, thereby protecting hepatocytes from damage. Studies indicate that improved antioxidant capacity can halt or even reverse the progression of fatty liver disease. 2. Anti-Inflammatory Properties Inflammation plays a pivotal role in the progression of NAFLD to NASH. NAC has demonstrated anti-inflammatory effects through the inhibition of pro-inflammatory cytokines like TNF-alpha and IL-6. This property helps mitigate liver inflammation, reducing the risk of fibrosis and cirrhosis. 3. Improved Insulin Sensitivity NAFLD is closely associated with insulin resistance, a condition that exacerbates hepatic fat accumulation. NAC has been shown to enhance insulin sensitivity by reducing oxidative stress and inflammation in insulin-responsive tissues, including the liver, thereby addressing one of the root causes of NAFLD. 4. Lipid Metabolism Regulation Dysregulated lipid metabolism contributes significantly to NAFLD. NAC influences lipid profiles by decreasing serum triglycerides and low-density lipoprotein (LDL) levels while increasing high-density lipoprotein (HDL) levels. These changes help reduce hepatic steatosis and improve overall liver health. 5. Fibrosis Prevention Advanced NAFLD often leads to liver fibrosis, a precursor to cirrhosis. NAC helps inhibit fibrogenesis by reducing oxidative stress and inflammation, two key drivers of fibrosis. Furthermore, it modulates hepatic stellate cell activity, which is responsible for extracellular matrix deposition during fibrosis. 6. Hepatoprotective Effects in Drug-Induced Liver Injury Many patients with NAFLD have co-existing conditions requiring pharmacological interventions, which may exacerbate liver damage. NAC is widely recognized for its hepatoprotective role in drug-induced liver injury, particularly in acetaminophen toxicity, suggesting its utility in protecting the liver from additional insults in NAFLD. 7. Enhanced Mitochondrial Function Mitochondrial dysfunction is a critical factor in NAFLD progression. NAC improves mitochondrial bioenergetics by maintaining glutathione levels, reducing reactive oxygen species (ROS), and enhancing ATP production. This restoration of mitochondrial function can halt liver damage and promote recovery. 8. Synergistic Effects with Other Therapies When used in combination with lifestyle changes or pharmacological treatments, NAC enhances their efficacy. For instance, its antioxidant properties can augment the effects of vitamin E or pioglitazone, common treatments for NAFLD, providing a more comprehensive therapeutic approach. 9. Safety and Tolerability NAC has a favorable safety profile, even at high doses, making it a viable long-term treatment option for NAFLD. Its minimal side effects and wide availability add to its appeal as an adjunctive therapy for managing the condition. 10. Potential Role in Advanced Stages of NAFLD While most treatments focus on early-stage NAFLD, NAC has shown promise in addressing advanced stages, including NASH and early fibrosis. Its broad mechanism of action, targeting oxidative stress, inflammation, and fibrogenesis, makes it a versatile option for comprehensive liver health management. General References What can I do to reduce the severity of NAFLD? NAC 500 mg is most frequently recommended to my patients, to be taken 3 times daily. Breakfast, Dinner and Bed time. N-acetyl cysteine for NAFLD To it, I frequently add L-Theanine 200 mg at bed time, to treat subclinical hepatitis and elevated liver enzymes. L-Theanine for non alcoholic Fatty liver disease Reduced Glutathione, 250 mg twice daily, taken only after trying the NAC and L-theanine Glutathione for NAFLD REFERENCES: 1. Angulo, P. (2002). Nonalcoholic fatty liver disease. New England Journal of Medicine, 346(16), 1221-1231. 2. Day, C. P., & James, O. F. W. (1998). Steatohepatitis: A tale of two "hits". Gastroenterology, 114(4), 842-845. 3. Sanyal, A. J., et al. (2001). Oxidative stress and hepatic apoptosis in non-alcoholic fatty liver disease. Journal of Clinical Investigation, 108(7), 1071-1078. 4. Pessayre, D., et al. (2005). Mitochondria in steatohepatitis. Seminars in Liver Disease, 25(1), 41-54. 5. Nagy, L. E. (2003). Recent insights into the role of the innate immune system in the development of alcoholic liver disease. Experimental Biology and Medicine, 228(8), 882-890. 6. Polyzos, S. A., et al. (2010). Nonalcoholic fatty liver disease: The pathogenetic roles of insulin resistance and adipocytokines. Current Molecular Medicine, 10(6), 579-588. 7. Younossi, Z. M., et al. (2016). Global epidemiology of NAFLD-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology, 64(1), 73-84. 8. Brunt, E. M., et al. (1999). Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions. American Journal of Gastroenterology, 94(9), 2467-2474. 9. Chalasani, N., et al. (2018). The diagnosis and management of nonalcoholic fatty liver disease. Practice Guidelines, AASLD. 10. Marí, M., et al. (2006). Mitochondrial glutathione, a key survival antioxidant. Antioxidants & Redox Signaling, 8(7-8), 1373-1385. David S. Klein, MD Functional Medicine Physician David S. Klein, MD FACA FACPM David S. Klein, MD, FACA, FACPM 1917 Boothe Circle Longwood, Florida 32750 Tel: 407-679-3337 Fax: 407-678-7246

Why is Uric Acid level important enough that I should read this? How does Uric Acid Cause Heart Disease & Heart Attack? In short, modest elevations in uric acid level put you, your family, and your friends at increased risk of developing preventable heart disease, heart attack and sudden death. Have you ever wondered why some of your acquaintances have suddenly had heart attacks or dropped dead without much notice that they had heart disease? Have you ever wondered why heart disease occurs without having particularly high cholesterol levels? If this gets your attention, please read on........ Uric acid, a byproduct of purine metabolism, has been increasingly recognized as a potential contributor to cardiovascular diseases, including heart attacks. Elevated serum uric acid (SUA) levels, also known as hyperuricemia, have long been associated with gout, but emerging evidence suggests a significant link between hyperuricemia and adverse cardiovascular outcomes . This relationship is particularly concerning given the increasing prevalence of hyperuricemia worldwide. Hyperuricemia has been implicated in the development of endothelial dysfunction, which plays a critical role in the initiation and progression of athero sclerosis—a major precursor to myocardial infarction. At relatively modest concentrations, Uric Acid crystalizes and these small crystals can damage the inner lining of the arteries, destroying the lining called the Glycocalyx. Elevated uric acid levels can induce oxidative stress and inflammation in endothelial cells, impairing nitric oxide bioavailability and promoting vascular stiffness. These mechanisms establish a direct pathophysiological link between uric acid and cardiovascular risk (Becker & Jolly, 2006). What Uric Acid level seems to be the threshold for causing heart disease? This is where the fun begins. Numerous epidemiological studies have shown a correlation between elevated SUA levels and an increased risk of coronary artery disease and heart attacks. A meta-analysis of over 16 studies involving more than 200,000 participants found that individuals with hyperuricemia had a 20-40% higher risk of coronary heart disease compared to those with normal SUA levels (Li et al., 2014). The risk of heart disease increases and the risk of serious damage begins at the level of 5.5 mg/dl. This is well below the level seen as 'high' or consistent with Gout. (please see my other Blog on Uric Acid for the data & reference) This association remained significant even after adjusting for traditional cardiovascular risk factors such as hypertension, diabetes, and hyperlipidemia. The role of uric acid as an independent risk factor for heart attacks has been debated, partly because hyperuricemia often coexists with other metabolic disorders. For instance, hyperuricemia is frequently associated with hypertension, insulin resistance, and obesity, all of which are established cardiovascular risk factors (Feig et al., 2008). While these conditions may confound the relationship, experimental evidence supports a direct role for uric acid in cardiovascular pathophysiology. Uric acid has also been linked to the activation of the renin-angiotensin-aldosterone system (RAAS) and increased production of inflammatory cytokines, further exacerbating cardiovascular risk. Elevated SUA levels can lead to renal microvascular damage, promoting hypertension—a well-known risk factor for myocardial infarction (Mazzali et al., 2001). This interaction highlights the systemic impact of hyperuricemia on cardiovascular health. Clinical studies have suggested that reducing uric acid levels through pharmacological interventions, such as allopurinol or febuxostat , may mitigate cardiovascular risk. For instance, a randomized controlled trial found that allopurinol improved endothelial function and reduced arterial stiffness in patients with hyperuricemia (Kanbay et al., 2011). While these findings are promising, further research is needed to confirm the cardiovascular benefits of uric acid-lowering therapy. Gender differences in the relationship between uric acid and cardiovascular risk have also been observed. Women, particularly premenopausal women, appear to have a weaker association between hyperuricemia and heart attacks compared to men, possibly due to the uricosuric effects of estrogen. However, postmenopausal women show a similar risk profile to men, underscoring the complex interplay between sex hormones and uric acid metabolism (Chen et al., 2015). Hyperuricemia has also been associated with the formation of microvascular thrombi, which can contribute to acute coronary syndromes. Uric acid crystals can activate the NLRP3 inflammasome, leading to the release of interleukin-1β and subsequent inflammatory cascades that destabilize atherosclerotic plaques (Martinon et al., 2006). These processes further elucidate the mechanistic link between uric acid and myocardial infarction. Despite the growing evidence, some experts argue that uric acid may serve more as a marker of cardiovascular risk rather than a causative factor. This perspective emphasizes the need for well-designed longitudinal studies and clinical trials to disentangle the complex relationship between SUA levels and heart attacks (Kuwabara et al., 2018). In conclusion, elevated uric acid levels are strongly associated with an increased risk of heart attack through multiple mechanisms, including endothelial dysfunction, oxidative stress, and inflammation. While hyperuricemia is often intertwined with other cardiovascular risk factors, it may also independently contribute to myocardial infarction. Addressing hyperuricemia through lifestyle modifications and pharmacological interventions could potentially reduce cardiovascular risk, but further research is essential to validate these strategies. What can I realistically do to address this potential problem? Get your uric acid level checked regularly. At my practice, Stages of Life Medical Institute, we check our patients every 3 to 6 months. Maintain your level below 5.4 My preferred medication is Allopurinol. Starting dosage is 100 mg tablet, 2 in the morning. Titrate the dosage upward after subsequent blood work confirms the level and suggests a change, usually an increase in dosage. Eat sensibly. Go to your favorite search engine and read about what foods are good for patients with gout, and you are well on your way to getting this under control. In my practice, I have found that the CRP levels, used to look for inflammation decrease substantially when the uric acid levels are lowered below 4.2 mg/dl. References 1. Becker, M. A., & Jolly, M. (2006). Hyperuricemia and associated diseases. Rheumatic Disease Clinics of North America, 32(2), 275-293. 2. Li, M., Hou, W., Zhang, X., Hu, L., Tang, Z., & Wang, C. (2014). Hyperuricemia and risk of stroke: a systematic review and meta-analysis of prospective studies. Atherosclerosis, 232(2), 265-270. 3. Feig, D. I., Kang, D. H., & Johnson, R. J. (2008). Uric acid and cardiovascular risk. New England Journal of Medicine, 359(17), 1811-1821. 4. Mazzali, M., Hughes, J., Kim, Y. G., et al. (2001). Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension, 38(5), 1101-1106. 5. Kanbay, M., Ozkara, A., Selcoki, Y., et al. (2011). Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearance, and proteinuria in patients with normal renal functions. International Urology and Nephrology, 39(4), 1227-1233. 6. Chen, L., Zhu, W., & Chen, Z. (2015). Gender and age specific prevalence of hyperuricemia and its associated risk factors in Chinese adults: A longitudinal study. BMC Public Health, 15(1), 537. 7. Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006). Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature, 440(7081), 237-241. 8. Kuwabara, M., Niwa, K., Nishi, Y., et al. (2018). Relationship between serum uric acid levels and cardiovascular disease risk factors in a Japanese cohort. Journal of Cardiology, 71(3), 283-288. 9. Borghi, C., & Cicero, A. F. G. (2016). Serum uric acid and cardiovascular risk: state of the art and future perspectives. Current Cardiology Reports, 18(2), 118. 10. Gagliardi, A. C., Miname, M. H., & Santos, R. D. (2009). Uric acid: A marker of increased cardiovascular risk. Atherosclerosis, 202(1), 11-17. David S. Klein, MD, FACA, FACPM 1917 Boothe Circle Longwood, Florida 32750 Tel: 407-679-3337 Fax: 407-678-7246

How does Berberine lower blood sugar and reduce triglycerides & cholesterol? Berberine, a bioactive compound extracted from various plants, has intrigued the health and wellness community for its impressive healing properties. Berberine is an isoquinoline alkaloid derived from the roots and stem bark of the Berberis L. plant. It is an antihyperglycemic drug that inhibits the efficiency of disaccharidases, reducing glucose transport through the intestinal epithelium. This golden yellow alkaloid has been used in traditional medicine for centuries, especially in Chinese and Ayurvedic practices. With increasing interest in herbal remedies, berberine is being regarded as a powerful natural healer. In this post, we explore berberine's numerous benefits, mechanisms of action, and practical applications. What is Berberine? Berberine is a natural compound chiefly found in plants like Berberis vulgaris (barberry), Coptis chinensis (Chinese goldthread), and Hydrastis canadensis (goldenseal). I mportant to note, is that the amount of the alkaloid varies from species to species, variety to variety. This unique bioactive agent has garnered a reputation for its varied pharmacological effects, with roots in traditional medicine due to its antimicrobial, anti-inflammatory, and blood sugar-regulating properties. Many health enthusiasts consider berberine one of the most potent natural supplements for various conditions, such as type 2 diabetes and high cholesterol. Its diverse composition enables it to influence several physiological pathways, making it a versatile compound for boosting health. How Does Berberine Work? Berberine's effectiveness stems from its ability to influence multiple cellular pathways. Primarily, it activates an enzyme called AMP-activated protein kinase (AMPK) , crucial for maintaining energy balance and metabolic regulation. By triggering AMPK, berberine enhances glucose absorption in cells and boosts fat metabolism, which is particularly beneficial for people with insulin resistance. Research shows that berberine can modify the gut microbiota, which is important for metabolic health. For example, a study found that berberine increased the levels of beneficial bacteria by 34% , promoting better digestion and nutrient absorption that supports overall health. Health Benefits of Berberine Blood Sugar Regulation Berberine's ability to manage blood sugar is one of its most significant benefits. Studies indicate that berberine can lower fasting blood glucose levels by approximately 20% and improve insulin sensitivity by around 30% . For individuals with type 2 diabetes, these effects can be transformative, providing a natural approach to blood sugar control. Cholesterol and Heart Health In terms of heart health, berberine appears to improve lipid profiles significantly. Research has shown it can reduce total cholesterol levels by 22% , LDL (bad) cholesterol by 25% , and triglycerides by 30% , while increasing HDL (good) cholesterol by 15% . These changes suggest that incorporating berberine might lower the risk of cardiovascular diseases. Weight Management The association between berberine and weight management is gaining ground. Studies show that when combined with a healthy diet and exercise, berberine can help reduce body weight by as much as 5% over a three-month period. This effect results from its ability to enhance fat metabolism and curb fat storage. Antimicrobial and Anti-Inflammatory Properties Berberine is well-known for its antimicrobial properties, proving effective against a range of pathogens, including bacteria and fungi. For instance, it has been shown in laboratory settings to inhibit Staphylococcus aureus , a common bacterium responsible for various infections. Its anti-inflammatory effects are equally remarkable. Chronic inflammation can contribute to health issues like arthritis and heart disease. Berberine's ability to reduce inflammation markers by 20% in some studies showcases its potential in alleviating chronic conditions. Practical Applications of Berberine Supplementation Berberine comes in several forms, including capsules and tinctures. A common recommendation for optimal supplementation ranges from 500 mg to 1500 mg daily , often split into multiple doses. Initiating a supplementation plan should always be done in consultation with a healthcare provider to tailor it to individual health needs. Dietary Sources Including berberine-rich foods can complement supplementation. Foods derived from barberry or goldenseal are good choices, although the concentration of berberine is generally lower than in supplement form, which may necessitate additional supplementation for desired health effects. Basically, it is impractical to obtain sufficient berberine from ordinary food sources. Lifestyle Interventions To enhance the efficacy of berberine, integrating a holistic approach to health is essential. Adopting a balanced diet, engaging in regular physical activity, and managing stress significantly amplifies its positive impacts. Activities like yoga, meditation, and prioritizing sleep can further support overall wellness. Safety and Considerations Berberine is typically safe for most people, yet it can interact with certain medications like blood thinners and diabetes treatments. Side effects, including gastrointestinal discomfort such as bloating or constipation, may occur, more commonly, the consumer will initially experience loosening of their bowel movements. Weight loss can be expected, although it tends to be modest, at first. As with all interventions of this nature, it is best to consult with your healthcare professional before starting any new supplement is advisable to ensure it aligns well with your health circumstances. Embracing the Power of Berberine Berberine is an intriguing compound with significant healing potential. Its abilities to regulate blood sugar, improve cholesterol levels, aid in weight management, and combat infections position it as an essential ingredient in contemporary health practices. As research continues to illuminate its benefits, incorporating berberine into a balanced lifestyle may enhance overall health. By understanding the healing characteristics of berberine, individuals can take informed steps toward natural remedies that support their well-being. Through thoughtful supplementation, dietary adjustments, and lifestyle improvements, we can unlock the numerous advantages berberine offers, enriching our journey toward better health. More to come! Berberine may decrease the incidence of cancer, and interestingly, it may assist in prolonging survival if you happen to suffer from cancer. David Stephen Klein, MD, FACA, FACPM 1917 Boothe Circle Longwood, Florida 32750 407-679-3337 www.suffernomore.com

N-acetylcysteine (NAC), a derivative of the amino acid L-cysteine, has garnered attention for its potential therapeutic applications in thyroid diseases, particularly autoimmune thyroid conditions like Hashimoto's thyroiditis. (Personally, I have been taking the supplement for over 10 years for my own autoimmune condition.) As a precursor to glutathione, a vital antioxidant, NAC plays a significant role in mitigating oxidative stress and supporting detoxification processes, which are crucial in managing thyroid health. Oxidative stress, characterized by an imbalance between free radicals and antioxidants, is implicated in the pathogenesis of various thyroid disorders. Elevated oxidative stress can damage thyroid cells, leading to dysfunction. NAC contributes to the synthesis of glutathione, enhancing the body's antioxidant defenses and potentially reducing oxidative damage within the thyroid gland. In Hashimoto's thyroiditis, an autoimmune condition where the immune system attacks thyroid tissue, NAC's antioxidant properties may help modulate immune responses. By reducing oxidative stress, NAC could decrease the inflammatory processes that contribute to thyroid tissue damage, thereby supporting thyroid function. Detoxification is another critical aspect of thyroid health. The thyroid gland is susceptible to environmental toxins, which can disrupt its function. NAC supports liver detoxification pathways, aiding in the elimination of harmful substances that may adversely affect the thyroid. This detoxifying action is particularly beneficial for individuals with thyroid disorders, as it helps maintain a cleaner internal environment conducive to optimal thyroid function. Beyond its antioxidant and detoxifying roles, NAC has been studied for its potential to reduce thyroid antibodies. Elevated thyroid antibodies are a hallmark of autoimmune thyroid diseases and are associated with disease progression. Some research suggests that NAC supplementation may lower these antibody levels, indicating a possible therapeutic avenue for managing autoimmune thyroid conditions. NAC's benefits extend to gut health, which is intricately linked to thyroid function. Intestinal permeability, or "leaky gut," has been associated with Hashimoto's Thyroiditis and other autoimmune thyroid diseases. NAC may help improve gut barrier integrity, reducing the translocation of antigens that could trigger or exacerbate autoimmune responses against the thyroid. Use knowingly, carefull and with caution when treating Hashimoto's Thyroiditis While NAC shows promise, it's essential to approach supplementation with caution. Self-medication, especially in older adults, can lead to unintended consequences. For instance, there have been reports of hyperthyroidism related to NAC use, underscoring the need for medical supervision when considering NAC for thyroid health. NAC, it seems, can get the inflammation from Hashimoto's Thyroiditis under improved control, very, very quickly. The standard treatment for hypothyroidism involves thyroid hormone replacement therapy. Clinical guidelines emphasize the importance of individualized treatment plans and caution against unverified alternative therapies. While NAC may offer supportive benefits, it should not replace conventional treatments without professional guidance. In summary, NAC's antioxidant, detoxifying, and potential immunomodulatory properties make it a compound of interest in the context of thyroid diseases. However, further research is necessary to fully elucidate its efficacy and safety. Patients should consult healthcare providers before initiating NAC supplementation to ensure it aligns with their overall treatment strategy and health status. Note: The dosage schedule recommended by this office is: NAC 500 mg capsules, taken 4 times daily. Breakfast, Lunch, Dinner and Bed time. References: Here are several PubMed references that explore the role of N-acetylcysteine (NAC) in thyroid disease: N-acetylcysteine in the treatment of Hashimoto's thyroiditis: A pilot study Authors:  Mazokopakis EE, Papadakis JA, Papadomanolaki MG, Batistakis AG, Giannakopoulos TG, Protopapadakis EE, Ganotakis ES. Journal:   ThyroidYear:  2012 DOI:  10.1089/thy.2011.0319 Summary:  This pilot study investigated the effects of NAC supplementation on patients with Hashimoto's thyroiditis, focusing on thyroid antibody levels and thyroid function. The effect of N-acetylcysteine on oxidative stress in patients with subclinical hypothyroidism Authors:  Erdamar H, Demirci H, Yaman H, Erbil MK, Yakar T, Sancak B, Elbeg S, Biberoglu G, Yetkin I. Journal:   Acta Endocrinologica (Bucharest)Year:  2014 DOI:  10.4183/aeb.2014.15 Summary:  This study evaluated the impact of NAC on oxidative stress markers in individuals with subclinical hypothyroidism, suggesting potential benefits in reducing oxidative damage. N-acetylcysteine as a potential treatment for autoimmune thyroid disease Authors:  Mazokopakis EE, Papadakis JA. Journal:   ThyroidYear:  2013 DOI:  10.1089/thy.2012.0560 Summary:  The authors discuss the therapeutic potential of NAC in managing autoimmune thyroid diseases, particularly through its antioxidant properties. Oxidative stress in thyroid diseases Authors:  Mancini A, Di Donna V, Leone E, Festa R, Silvestrini A, Meucci E, Pontecorvi A. Journal:   European Review for Medical and Pharmacological SciencesYear:  2013 PMID:  23852999 Summary:  This review highlights the role of oxidative stress in thyroid disorders and discusses antioxidants, including NAC, as potential therapeutic agents. Antioxidant therapy in autoimmune thyroiditis: An update Authors:  Benvenga S, Guarneri F. Journal:   Journal of Endocrinological Investigation Year:  2013 DOI:  10.1007/BF03345748 Summary:  The article reviews the use of antioxidants, such as NAC, in the treatment of autoimmune thyroiditis, emphasizing their role in reducing oxidative stress. These references provide insights into the potential applications of NAC in thyroid disease management, particularly concerning its antioxidant properties and effects on autoimmune thyroid conditions. David S. Klein, MD, FACA, FACPM 1917 Boothe Circle Longwood, Florida 32750 Tel: 407-679-3337 Fax: 407-678-7246